Brief: Yichang Hec Changjiang Pharmaceutical Sees HY Net Profit Attributable To Decrease
Aug 20 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* NET PROFIT ATTRIBUTABLE FOR HY EXPECTED TO DECREASE BY
ABOUT
180-190%
* EXPECTED RESULT DUE TO RAPID DECLINE IN TRAFFIC OF
PATIENTS IN
TERMINAL MEDICAL INSTITUTIONS
Source text for Eikon: ID:nHKS5H6WWv
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million